TY - JOUR
T1 - Smartphone-Guided Self-prone Positioning vs Usual Care in Nonintubated Hospital Ward Patients With COVID-19
T2 - A Pragmatic Randomized Clinical Trial
AU - Rampon, Garrett
AU - Jia, Shijing
AU - Agrawal, Ritwick
AU - Arnold, Nicholas
AU - Martín-Quirόs, Alejandro
AU - Fischer, Ernest A.
AU - Malatack, James
AU - Jagan, Nikhil
AU - Sergew, Amen
AU - Case, Amy Hajari
AU - Miller, Kristin
AU - Tanios, Maged
AU - Doros, Gheorghe
AU - Ross, Craig S.
AU - Garcia, Michael A.
AU - Gillmeyer, Kari R.
AU - Griffiths, Nicholas G.
AU - Jandali, Badr
AU - Modzelewski, Katherine L.
AU - Rucci, Justin M.
AU - Simpson, Steven Q.
AU - Walkey, Allan J.
AU - Bosch, Nicholas A.
N1 - Funding Information:
Author contributions: All authors assume responsibility for the overall content and integrity of the article. G. R. A. J. W. S. Q. S. G. D. C. S. R. and N. A. B. drafted the initial version of the manuscript, and all members of the writing committee edited and approved subsequent versions. Financial/nonfinancial disclosures: The authors have reported to CHEST the following: K. M. is the Primary Investigator for the industry-funded trial NCT03808922 (STOP PIV-Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects). None declared (G. R. S. J. R. A. N. A. A. M.-Q. E. A. F. J. M. N. J. A. S. A. H. C. M. T. G. D. C. S. R. M. A. G. K. R. G. N. G. G. B. J. K. L. M. J. M. R. S. Q. S. A. J. W. N. A. B.). Funding/support: The study was funded by the National Center for Advancing Translational Sciences, National Institutes of Health, through Boston University-Clinical and Translational Science Institute [Grant 1UL1TR001430]. Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. Disclaimer: The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. APPEX-19 Collaborators: A complete list of collaborators in the APPEX-19 trial is provided in e-Appendix 3. Other contributions: The authors thank the participating patients in this trial; the allied health professionals, institutional review boards, research assistants, and research administrators at the 12 APPEX-19 sites in the United States and Spain (e-Appendix 3), especially Charlotte Alger, BS, and Mary-Tara Roth, RN, MSN, MPH; and the members of the independent data monitoring committee (Arthur C. Theodore, MD; Hasmeena Kathuria, MD; and Robert A. Lew, PhD). Additional information: The e-Appendixes, e-Figures, and e-Tables are available online under “Supplementary Data.”
Funding Information:
Funding /support: The study was funded by the National Center for Advancing Translational Sciences , National Institutes of Health , through Boston University-Clinical and Translational Science Institute [Grant 1UL1TR001430].
Publisher Copyright:
© 2022 American College of Chest Physicians
PY - 2022/10
Y1 - 2022/10
N2 - Background: Safe, effective, and easily implementable treatments that reduce the progression of respiratory failure in COVID-19 are urgently needed. Despite the increased adoption of prone positioning during the pandemic, the effectiveness of this technique on progression of respiratory failure among nonintubated patients is unclear. Research Question: What is the effectiveness of smartphone-guided self-prone positioning recommendations and instructions compared with usual care in reducing progression of respiratory failure among nonintubated patients with COVID-19? Study Design and Methods: Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) is a multicenter randomized clinical trial that randomized nonintubated adults with COVID-19 on < 6 L/min of supplemental oxygen to receive a smartphone-guided self-prone positioning intervention or usual care. The primary outcome was the composite of respiratory deterioration (an increase in supplemental oxygen requirement) or ICU transfer. Using a Bayesian statistical approach, the posterior probability of superiority within each treatment arm (superiority threshold 95%) was calculated. Results: The trial was stopped early for slow enrollment. A total of 293 participants were included in the modified intention-to-treat analysis (159 self-prone positioning intervention and 134 usual care). Among participants who self-reported body positioning (n = 139 [70 intervention, 69 usual care]), 71.4% in the intervention arm and 59.4% in the usual care arm attempted prone positioning. Thirty-one participants (posterior mean, 24.7%; 95% credible interval, 18.6-31.4) receiving usual care and 32 participants (posterior mean, 22.1%; 95% credible interval, 16.6-28.1) receiving the self-prone positioning intervention experienced the primary outcome; the posterior probability of superiority for the self-prone positioning intervention was 72.1%, less than the 95% threshold for superiority. Adverse events occurred in 26.9% of participants in the usual care arm and in 11.9% of participants in the intervention arm. Interpretation: Among nonintubated patients with COVID-19, smartphone-guided self-prone positioning recommendations and instructions did not promote strong adherence to prone positioning. Clinical Trial Registration: ClinicalTrials.gov; No.: NCT04344587; URL: www.clinicaltrials.gov.
AB - Background: Safe, effective, and easily implementable treatments that reduce the progression of respiratory failure in COVID-19 are urgently needed. Despite the increased adoption of prone positioning during the pandemic, the effectiveness of this technique on progression of respiratory failure among nonintubated patients is unclear. Research Question: What is the effectiveness of smartphone-guided self-prone positioning recommendations and instructions compared with usual care in reducing progression of respiratory failure among nonintubated patients with COVID-19? Study Design and Methods: Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) is a multicenter randomized clinical trial that randomized nonintubated adults with COVID-19 on < 6 L/min of supplemental oxygen to receive a smartphone-guided self-prone positioning intervention or usual care. The primary outcome was the composite of respiratory deterioration (an increase in supplemental oxygen requirement) or ICU transfer. Using a Bayesian statistical approach, the posterior probability of superiority within each treatment arm (superiority threshold 95%) was calculated. Results: The trial was stopped early for slow enrollment. A total of 293 participants were included in the modified intention-to-treat analysis (159 self-prone positioning intervention and 134 usual care). Among participants who self-reported body positioning (n = 139 [70 intervention, 69 usual care]), 71.4% in the intervention arm and 59.4% in the usual care arm attempted prone positioning. Thirty-one participants (posterior mean, 24.7%; 95% credible interval, 18.6-31.4) receiving usual care and 32 participants (posterior mean, 22.1%; 95% credible interval, 16.6-28.1) receiving the self-prone positioning intervention experienced the primary outcome; the posterior probability of superiority for the self-prone positioning intervention was 72.1%, less than the 95% threshold for superiority. Adverse events occurred in 26.9% of participants in the usual care arm and in 11.9% of participants in the intervention arm. Interpretation: Among nonintubated patients with COVID-19, smartphone-guided self-prone positioning recommendations and instructions did not promote strong adherence to prone positioning. Clinical Trial Registration: ClinicalTrials.gov; No.: NCT04344587; URL: www.clinicaltrials.gov.
UR - http://www.scopus.com/inward/record.url?scp=85138531459&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85138531459&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2022.05.009
DO - 10.1016/j.chest.2022.05.009
M3 - Article
C2 - 35597286
AN - SCOPUS:85138531459
SN - 0012-3692
VL - 162
SP - 782
EP - 791
JO - Diseases of the chest
JF - Diseases of the chest
IS - 4
ER -